Immunohistochemical detection of the ALK protein has been available for many years for the diagnosis of anaplastic large-cell lymphoma [11,12], but the antibodies traditionally used in the diagnosis of this lymphoma are insufficiently sensitive for detection at the level at which ALK is expressed in ALK-rearranged lung cancers. This evidence concerns the gene ALK and lung carcinoma.